Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine A Foss

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2022
PET/CT imaging of CSF1R in a mouse model of tuberculosisCatherine A Foss, Alvaro A Ordonez, Ravi Naik, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2011
Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigenSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
International Journal of Molecular Sciences|September 16, 2020
Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional CharacterizationZora Novakova, Nikola Belousova, Catherine A Foss, et al.
Thyroid : Official Journal of the American Thyroid Association|May 17, 2011
Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodideJulia Reinfelder, Simone Maschauer, Catherine A Foss, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2017
PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cellsJong-Sung Park, Yumin Oh, Ogyi Park, et al.
Journal of Medicinal Chemistry|July 22, 2008
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)Sangeeta R Banerjee, Catherine A Foss, Mark Castanares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2018
Biodistribution and Radiation Dosimetry of <sup>124</sup>I-DPA-713, a PET Radiotracer for Macrophage-Associated InflammationCatherine A Foss, Donika Plyku, Alvaro A Ordonez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancerCatherine A Foss, Ronnie C Mease, Hong Fan, et al.
Journal of Medicinal Chemistry|December 5, 2008
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancerYing Chen, Catherine A Foss, Youngjoo Byun, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2022
PET/CT imaging of CSF1R in a mouse model of tuberculosisCatherine A Foss, Alvaro A Ordonez, Ravi Naik, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2011
Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigenSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
International Journal of Molecular Sciences|September 16, 2020
Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional CharacterizationZora Novakova, Nikola Belousova, Catherine A Foss, et al.
Thyroid : Official Journal of the American Thyroid Association|May 17, 2011
Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodideJulia Reinfelder, Simone Maschauer, Catherine A Foss, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2017
PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cellsJong-Sung Park, Yumin Oh, Ogyi Park, et al.
Journal of Medicinal Chemistry|July 22, 2008
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)Sangeeta R Banerjee, Catherine A Foss, Mark Castanares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2018
Biodistribution and Radiation Dosimetry of <sup>124</sup>I-DPA-713, a PET Radiotracer for Macrophage-Associated InflammationCatherine A Foss, Donika Plyku, Alvaro A Ordonez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancerCatherine A Foss, Ronnie C Mease, Hong Fan, et al.
Journal of Medicinal Chemistry|December 5, 2008
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancerYing Chen, Catherine A Foss, Youngjoo Byun, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Pageof 8